The Women's Oncology Review, Volume 6, Issue 3-4 (2006)

Browse this journal

The Women's Oncology Review, Volume 6, Issue 3-4 (2006)

See all volumes and issues
Volume 6, 2006-2007 Vol 5, 2005 Vol 4, 2004
Download citations Download PDFs Download issue

Editorial Article

Editorial
Editorial
Thomas Herzog, Robert Coleman & Kris Ghosh
Page: 119
Published online: 04 Dec 2011
CitationforEditorial | PDF (20.9 KB)
  • 4 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Uterine leiomyosarcomas
N. Bansal, J. D. Wright & T. J. Herzog
Pages: 121-126
Published online: 04 Dec 2011
First Page PreviewforUterine leiomyosarcomas | References | PDF (112.1 KB)
  • 1 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Vascular endothelial growth factor (VEGF) inhibitorsin cancer therapy: an update
Jade Homsi, Lori C. Kim, Pamela N. Munster, Catherine Chodkiewicz & Adil Daud
Pages: 127-136
Published online: 04 Dec 2011
AbstractforVascular endothelial growth factor (VEGF) inhibitorsin cancer therapy: an update | References | PDF (405.4 KB)
  • 3 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Taxanes as adjuvant therapy for breast cancer
Miguel Martin
Pages: 137-144
Published online: 04 Dec 2011
AbstractforTaxanes as adjuvant therapy for breast cancer | References | PDF (147 KB)
  • 1 Views
  • 0 CrossRef citations
  • 0Altmetric

Commentary

Article Commentary
Chemoprevention for breast cancer: beyond tamoxifen
Vogel C, et al. Effects of Tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2727–2741.
Agustin A. Garcia
Pages: 145-147
Published online: 04 Dec 2011
First Page PreviewforChemoprevention for breast cancer: beyond tamoxifen | References | PDF (68.3 KB)
  • 1 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
What is the optimal duration and treatment sequence of trastuzumab in the adjuvant setting?
Joensuu H, et al. Adjuvant docetaxel or vinorelbine with our without Trastuzumab for breast cancer. N Engl J Med 2006;354:809–820.
Agustin A. Garcia
Pages: 149-151
Published online: 04 Dec 2011
First Page PreviewforWhat is the optimal duration and treatment sequence of trastuzumab in the adjuvant setting? | References | PDF (71.3 KB)
  • 2 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Adjuvant chemotherapy for women with breast cancer with 10 or more positive axillary lymph nodes—will less mean more?
Montero AJ, et al. The natural history of breast carcinoma in patients with >10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy. Cancer 2005;104(2):229–235.
Aswini Padmanabhan & Agustin A. Garcia
Pages: 153-156
Published online: 04 Dec 2011
First Page PreviewforAdjuvant chemotherapy for women with breast cancer with 10 or more positive axillary lymph nodes—will less mean more? | References | PDF (85.5 KB)
  • 2 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Functional limitations in elderly women following cancer diagnosis
Sweeney C, Schmitz K, Lazovich D, Virnig B, Wallace R, Folsom A. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 2006;98:521–529.
David Palchak
Pages: 157-158
Published online: 04 Dec 2011
CitationforFunctional limitations in elderly women following cancer diagnosis | References | PDF (54 KB)
  • 5 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Pseudomyxoma peritonei: A case series and review of the literature
Brigitte Miller
Article Commentary | Published online: 4 Dec 2011
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor α activity
Paraskevi Vogiatzi
Article Commentary | Published online: 4 Dec 2011
The use of cytoprotectants in the treatment of gynecological malignancies
David H. Wei et al.
Review Article | Published online: 4 Dec 2011
Post-mastectomy radiation for breast cancer patients with small tumors and one to three positive lymph nodes
Wendy A. Woodward
Article Commentary | Published online: 4 Dec 2011